What is Polycystic Ovary Syndrome

Polycystic Ovary Syndrome (PCOS) is a complex endocrine and metabolic disorder characterized by hormonal imbalances that affect ovulation, often resulting in irregular menstrual cycles, androgen excess, and the development of small fluid-filled sacs on the ovaries.

Systems Affected and Pathophysiology

While the name Polycystic Ovary Syndrome suggests a primary reproductive issue, it is a systemic condition. It primarily impacts the reproductive system, causing irregular or absent periods and difficulties with fertility. However, it also significantly affects the endocrine system by causing insulin resistance—a state where the body does not use insulin effectively—which can lead to weight gain, acne, and hirsutism (excess body hair). Furthermore, the nervous system is frequently impacted, as many individuals with Polycystic Ovary Syndrome report higher rates of anxiety and depression, likely linked to both hormonal fluctuations and the psychological burden of chronic symptoms.

Prevalence and Demographics

Polycystic Ovary Syndrome is one of the most common endocrine disorders in people assigned female at birth, affecting an estimated 5% to 10% of this population globally. Symptoms typically emerge during adolescence or early adulthood, though the condition is often not formally diagnosed until an individual experiences trouble conceiving. It does not discriminate by geography, though clinical presentation can vary significantly between individuals based on genetics, lifestyle, and environment.

Differentiating Features

Unlike other conditions causing pelvic pain or irregular bleeding, Polycystic Ovary Syndrome is defined by a specific constellation of clinical criteria known as the Rotterdam Criteria. To be diagnosed, an individual typically must meet two out of three criteria: irregular or absent ovulation, clinical or biochemical signs of androgen excess (like acne or hair growth), and the presence of polycystic ovaries on an ultrasound. It is distinct from primary ovarian failure or simple hormonal fluctuations because of its strong metabolic component, specifically its association with insulin resistance.

Disclaimer: This information is for educational purposes only and does not constitute medical advice. Please consult a qualified healthcare provider for diagnosis and treatment plans tailored to your specific health history.

References

• NIH Genetic and Rare Diseases Information Center (GARD)


• Orphanet: The portal for rare diseases and orphan drugs


• The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group